Title: Balestrino M, et AL. Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle. Med Res Rev. 2019;39(6):2427-2459.
285979-69-3 | Ethan-1,1,2,2-d4-aminium, 2-hydroxy-N,N,N-trimethyl-, bromide (9CI) | AA002VPA | MFCD01075444
28691-50-1 | 6-Nitrobenzo[d]isoxazole-3-carboxylic acid | AA002W1C | MFCD20923247
28783-18-8 | 3-Bromothieno[3,2-c]pyridine | AA002WD0 | MFCD00041113
288266-54-6 | 2-([[3-(Trifluoromethyl)phenyl]sulfonyl]amino)propanoic acid | AA002WLR | MFCD00172805
28910-83-0 | (2-Amino-5-chlorophenyl)(2,6-difluorophenyl)methanone | AA002WYR | MFCD06659048
29113-33-5 | Ethyl 4-quinazolone-2-carboxylate | AA002XAK | MFCD00051583
29221-25-8 | Bicyclo[2.2.2]octane-2-carboxylic acid | AA002XOH | MFCD00180648
29329-99-5 | 1,2-Diphenyl-1h-indole-3-carbaldehyde | AA002XZI | MFCD00629119
29448-81-5 | 1H-Imidazo[4,5-b]pyridine-2-thiol | AA002YBI | MFCD00464846
2955-88-6 | 1-Pyrrolidineethanol | AA002YNZ | MFCD00003181